212 Tumor adjacent cytokine factories for eradication of ovarian cancer tumor burden in mice through cytotoxic T-cell activation with safe and predictable dosing in non-human primates
Amanda Nash(Rice University), Omid Veiseh(Rice University), Yufei Cui(Rice University), Rahul A. Sheth(Massachusetts General Hospital), Oleg A. Igoshin(Rice University), Maria Jarvis(Rice University), Sudip Mukherjee(Indian Institute of Technology BHU), Samira Aghlara-Fotovat(Integrated BioTherapeutics (United States)), José Oberholzer(University Hospital of Zurich), Andrea Hernández(Rice University), Sofia Ghani(TransUnion (United States)), Ira Joshi(TransUnion (United States)), Shirin Nouraein(Rice University), Andrew D. Hecht(Rice University), Peter Rios(TransUnion (United States)), Weiyi Peng(University of Houston), David Zhang(La Trobe University), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Douglas Isa(TransUnion (United States)), Chunyu Xu(University of Houston)
Cited by 0
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
|Advanced Drug Delivery Reviews|2009|1.8k
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
|Clinical Cancer Research|2013|938
Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates
|Nature Materials|2015|895
Electrospun chitosan-based nanofibers and their cellular compatibility
|Biomaterials|2005|888